Q: A guest on Market Call commented on Endo as a possible generic drug winner, albeit somewhat speculative as other small caps in this category. I would appreciate your assessment on this stock. Thank you!
Q: Currently underwater on this one and not sure if I should hold onto for another 3-6 months to see if it picks up any traction. Would you buy more, hold or sell.
Do you see any catalysts in that time frame for any appreciation?
Thanks Gary
In your answer to Peter, you listed the above companies for a healthcare watch list. Sorry to corner you by asking about your favorite and why?
CVS is cheap and has long-term promise, but I bet your choice will be between ANTM and HUM based on management. Will you endorse both for purchase in the near future? Why or why not?
Or will you prefer something completely outside this list?
Many thanks for your invaluable objectivity and guidance!
Q: Sangoma has sprung back to life lately on high volume. Any news or analyst recommendations that may have spurred the move? I have a half position and was looking to fill below 1.50 but it looks like I may not get the opportunity. What do you think?
Q: Would like your opinion on this stock a lot of the fundamentals look good low pe ,good dividend growth although it’s at a 52 week low would you consider this a good entry point or value trap?Also do you know if dividend is sustainable,EPS is 3.51 and paying out 1.80 looks good,also any near term catalysts and anything you know abouT management [ownership] thanks take as many questions as needed
Q: I would very much like your thoughts on "NBC Auto Callable Contingent Income Note Securities (Maturity-Monitored Barrier)" linked to the American market.
https://nbcstructuredsolutions.ca/detailProduit.aspx?lequel=04361&langue=en.
i see the principal is not protected if XSP-t drops 40%.
Q: Since the tax benefits for HXT, HXQ, HTB, HXS have or will be diminished, is there any reason to continue to hold them or should we be switching to other etf's, is so which ones would you recommend?
Thanks for your service.
Q: Hi 5i Team, If a portfolio is made up of ETF's how many is too much. I am worried about the MER's, since a few sector etf's have to be added to improve the sector allocation. Also how are the MER's calculated, is it a percentage of the total invested in that fund per year or something else.
Thanks guys. Have a great day.
Ivan
Q: Hello 5i,
I am holding 293 shares of XSTbought at $52.53 and up over $2000. Should I sell and buy VDC. I am 72 and use the portfolio for dividends and some growth.
thank you
Stanley
I've heard a about a new government regulation effecting swapped based ETFs. Does this new regulation effect HXQ and if so, would would be a good alternative to HXQ?